Cargando…

A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor

[Image: see text] Noroviruses are the major cause of human epidemic nonbacterial gastroenteritis. Viral replication requires a 3C cysteine protease that cleaves a 200 kDa viral polyprotein into its constituent functional proteins. Here we describe the X-ray structure of the Southampton norovirus 3C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussey, Robert J., Coates, Leighton, Gill, Raj S., Erskine, Peter T., Coker, Shu-Fen, Mitchell, Ed, Cooper, Jonathan B., Wood, Steve, Broadbridge, Robert, Clarke, Ian N., Lambden, Paul R., Shoolingin-Jordan, Peter M.
Formato: Texto
Lenguaje:English
Publicado: American Chemical Society 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058531/
https://www.ncbi.nlm.nih.gov/pubmed/21128685
http://dx.doi.org/10.1021/bi1008497
_version_ 1782200370738495488
author Hussey, Robert J.
Coates, Leighton
Gill, Raj S.
Erskine, Peter T.
Coker, Shu-Fen
Mitchell, Ed
Cooper, Jonathan B.
Wood, Steve
Broadbridge, Robert
Clarke, Ian N.
Lambden, Paul R.
Shoolingin-Jordan, Peter M.
author_facet Hussey, Robert J.
Coates, Leighton
Gill, Raj S.
Erskine, Peter T.
Coker, Shu-Fen
Mitchell, Ed
Cooper, Jonathan B.
Wood, Steve
Broadbridge, Robert
Clarke, Ian N.
Lambden, Paul R.
Shoolingin-Jordan, Peter M.
author_sort Hussey, Robert J.
collection PubMed
description [Image: see text] Noroviruses are the major cause of human epidemic nonbacterial gastroenteritis. Viral replication requires a 3C cysteine protease that cleaves a 200 kDa viral polyprotein into its constituent functional proteins. Here we describe the X-ray structure of the Southampton norovirus 3C protease (SV3CP) bound to an active site-directed peptide inhibitor (MAPI) which has been refined at 1.7 Å resolution. The inhibitor, acetyl-Glu-Phe-Gln-Leu-Gln-X, which is based on the most rapidly cleaved recognition sequence in the 200 kDa polyprotein substrate, reacts covalently through its propenyl ethyl ester group (X) with the active site nucleophile, Cys 139. The structure permits, for the first time, the identification of substrate recognition and binding groups in a noroviral 3C protease and thus provides important new information for the development of antiviral prophylactics.
format Text
id pubmed-3058531
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-30585312011-03-16 A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor Hussey, Robert J. Coates, Leighton Gill, Raj S. Erskine, Peter T. Coker, Shu-Fen Mitchell, Ed Cooper, Jonathan B. Wood, Steve Broadbridge, Robert Clarke, Ian N. Lambden, Paul R. Shoolingin-Jordan, Peter M. Biochemistry [Image: see text] Noroviruses are the major cause of human epidemic nonbacterial gastroenteritis. Viral replication requires a 3C cysteine protease that cleaves a 200 kDa viral polyprotein into its constituent functional proteins. Here we describe the X-ray structure of the Southampton norovirus 3C protease (SV3CP) bound to an active site-directed peptide inhibitor (MAPI) which has been refined at 1.7 Å resolution. The inhibitor, acetyl-Glu-Phe-Gln-Leu-Gln-X, which is based on the most rapidly cleaved recognition sequence in the 200 kDa polyprotein substrate, reacts covalently through its propenyl ethyl ester group (X) with the active site nucleophile, Cys 139. The structure permits, for the first time, the identification of substrate recognition and binding groups in a noroviral 3C protease and thus provides important new information for the development of antiviral prophylactics. American Chemical Society 2010-12-03 2011-01-18 /pmc/articles/PMC3058531/ /pubmed/21128685 http://dx.doi.org/10.1021/bi1008497 Text en Copyright © 2010 American Chemical Society http://pubs.acs.org This is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at http://pubs.acs.org.
spellingShingle Hussey, Robert J.
Coates, Leighton
Gill, Raj S.
Erskine, Peter T.
Coker, Shu-Fen
Mitchell, Ed
Cooper, Jonathan B.
Wood, Steve
Broadbridge, Robert
Clarke, Ian N.
Lambden, Paul R.
Shoolingin-Jordan, Peter M.
A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor
title A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor
title_full A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor
title_fullStr A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor
title_full_unstemmed A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor
title_short A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor
title_sort structural study of norovirus 3c protease specificity: binding of a designed active site-directed peptide inhibitor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058531/
https://www.ncbi.nlm.nih.gov/pubmed/21128685
http://dx.doi.org/10.1021/bi1008497
work_keys_str_mv AT husseyrobertj astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT coatesleighton astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT gillrajs astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT erskinepetert astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT cokershufen astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT mitchelled astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT cooperjonathanb astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT woodsteve astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT broadbridgerobert astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT clarkeiann astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT lambdenpaulr astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT shoolinginjordanpeterm astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT husseyrobertj structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT coatesleighton structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT gillrajs structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT erskinepetert structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT cokershufen structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT mitchelled structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT cooperjonathanb structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT woodsteve structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT broadbridgerobert structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT clarkeiann structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT lambdenpaulr structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor
AT shoolinginjordanpeterm structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor